Brief: Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI
30/06/2026 11:42
BRIEF-Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI June 30 (Reuters) - Biovica International AB BIOVICb.ST:
REFOCUSES US COMMERCIAL STRATEGY AND TERMINATES AGREEMENT WITH TEMPUS AI
COLLABORATION WITH TEMPUS DID NOT RESULT IN COMMERCIAL LAUNCH OR REVENUE
TERMINATION DOES NOT AFFECT SAN DIEGO LAB, US CLINICAL ACTIVITIES, OR PHARMA SERVICES
Source text: ID:nMFN9S9B53
Further company coverage: [BIOVICb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))